Articles

Demystifying Chromatographic Method Validation with John Dolan: Regulatory Guidelines and Lab Best Practices

Discover how to transition from regulatory anxiety to routine laboratory success with foundational guidelines from industry experts.
Written byShiama Thiageswaran
Presented byJohn Dolan
Abstract representation of chromatographic method validation with molecular structures.

​iStock

Register for free to listen to this article
Listen with Speechify
0:00
4:00

As defined by the International Council for Harmonization (ICH), the ultimate goal of this process is simple: to demonstrate that an analytical procedure is suitable for its intended use. According to industry pioneer John Dolan, a method need not be perfect for every scenario. Rather, it must demonstrate, with a reasonable degree of certainty, that it is robust enough for its intended, specific application.

What is Chromatographic Method Validation?

For laboratories entering the routine phase of testing, validation transitions from a daunting challenge into a systematic, predictable process. However, a lack of careful, organized execution can lead to critical deviations, regulatory audit failures, and costly rework. In the regulatory sphere, a foundational golden rule always applies: If it isn't documented, it didn't happen.

"Once you get into the routine, it’s just another laboratory process," Dolan notes, pointing out that a major secret to success lies in personnel management. "Part of the trick is identifying people who are particularly talented in this area. Some people do this well, and some don't."

Working in analytical science?

Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.

Subscribe for free

The Five Stages of Chromatographic Method Validation

To make the workflow manageable, Dolan breaks the complete validation lifecycle down into five distinct, sequential phases:

  1. Pre-validation and method development: The essential preparation and analytical insights required before formal, regulated testing begins.

  2. The validation process: The physical execution of the protocol and the completion of all mandatory documentation.

  3. Quality by Design (QbD) and robustness testing: Systematically designing quality into the method from its inception and testing its physical operational limits.

  4. Data analysis: Collecting, organizing, and evaluating the resulting data to draw statistically sound conclusions.

  5. Routine application: The successful, long-term transition of the validated method into daily laboratory operations.

Executing each of these sequential phases systematically helps ensure that the final analytical procedure is fully validated and fit for purpose.

Navigating Key Regulatory Bodies for Chromatographic Method Validation

Navigating the landscape of validation requires a deep understanding of regulations, which often hinge on interpretation by your laboratory and its quality unit. Depending on your industry—whether it is pharmaceuticals, environmental testing, or general chemical analysis—different organizations provide the framework for compliance.

1. The ICH Quality Guidelines

The ICH establishes the primary regulations surrounding drug substances (active ingredients) and drug products (formulated medicines). While the ICH charges a membership fee, its essential guidelines can be downloaded for free from the US Food and Drug Administration (FDA) website.

To help laboratories identify core standards, the most critical regulatory documents are organized into the "Q" (Quality) documents:

  • ICH Q2(R1) (Validation of analytical procedures: text and methodology): This is the foundational text for chromatographic validation, detailing specific tests that must be conducted to prove a method works. It is essential reading for anyone performing validation.
  • ICH Q8 (Pharmaceutical development): This standard details how to systematically design quality into an analytical method from its inception using Quality by Design principles.
  • ICH Q10 (Pharmaceutical quality system): This document outlines the structural requirements for companies building out a comprehensive quality system from scratch.

Familiarizing yourself with these foundational quality documents is an essential starting point for building a compliant regulatory framework in your own facility.

2. US FDA Guidance on Bioanalytical Method Validation

The FDA takes the regulatory lead on bioanalytical separations—the analysis of drugs in biological matrices such as plasma and tissue (not to be confused with the analysis of large biomolecules such as proteins).

To help laboratories align with federal expectations, the agency offers several key reference documents:

  • Bioanalytical method validation guidance: Unlike ICH regulations, FDA bioanalytical guidelines are "guidance," meaning they are strongly suggested rather than strict law. Deviations are acceptable, provided they are thoroughly documented and justified by sound science.
  • Crystal City papers: Generated from conferences held in Crystal City, these papers serve as crucial, expert updates to FDA bioanalytical guidance, establishing industry best practices (such as the ideal number of quality control samples).
  • FDA reviewer guidance for the validation of chromatographic methods: This is the training document the FDA gives to its own auditors. Reading it provides an excellent look into exactly what an investigator will look for when inspecting your laboratory's methods.

Understanding these guidance documents and reviewer criteria provides invaluable insights into regulatory expectations, helping laboratories prepare for smooth, successful audits.

3. Pharmacopeias (USP, EP, JP) and Compendial Verification

Pharmacopeial organizations compile official monographs detailing how to analyze specific compounds. A major benefit of using an official compendial monograph (such as one from the United States Pharmacopeia (USP)) is that the method does not require full validation; it only requires verification.

To assist chemists in executing this verification, key chapters within the USP include:

  • Chapter <1225> (Validation of compendial procedures): Mirroring ICH Q2(R1), this chapter applies if you are submitting a brand-new method to the USP, or if you have significantly modified an existing monograph.
  • Chapter <1226> (Verification of compendial procedures): The critical guide for bringing an unmodified, official monograph into your lab. It outlines the simplified verification testing required to prove the method functions correctly on your specific instrumentation.
  • Chapter <621> (Chromatography): A laboratory favorite, this chapter defines the precise "allowable adjustments" you can make to a run (such as minor flow rate tweaks) to pass system suitability without triggering a mandatory, expensive revalidation.

Appropriate use of these chapters allows laboratories to minimize unnecessary validation work through simplified compendial verification.

Pro-Tip: Free USP Digital Tools

While accessing the massive, multi-volume USP is a financial burden, Dolan highlights two powerful, free databases on the USP website that every chromatographer should utilize:

  • The monograph column database: USP monographs historically specify generic column codes, such as an "L1" column for C18. "But you don't have to be in the business long to realize all C18 columns are not created equal," warns Dolan. This database reveals the exact brand, model, and manufacturer of the column originally used to validate that specific monograph.
  • The column equivalency database: Featuring mathematical comparison data for over 600 reversed-phase columns, this tool helps chemists find direct equivalents in their existing inventory, avoiding the need to purchase brand-new column models.

Leveraging these free digital assets can significantly reduce laboratory budget while accelerating chromatographic method setup.

Continue reading below…
Webinarshero-220726
Expert Answers: GC Troubleshooting and Method Development
Help shape this expert-led presentation by submitting your questions on all things GC.
Read More

Embracing Chromatographic Method Validation as a Routine Asset

Ultimately, chromatographic method validation should not be approached as a source of regulatory anxiety. By understanding the core scientific intent behind global requirements, actively utilizing free compendial databases, and cultivating a culture of meticulous, real-time documentation, laboratories can transition this process from an intimidating regulatory hurdle into a highly predictable, routine asset.

Implementing these best practices does far more than satisfy compliance checklists; it establishes the foundation for analytical excellence, ensuring that every injection, peak, and reported value meets the highest standards of scientific integrity and audit scrutiny.

Continue Learning

Explore in-depth chromatography training courses from John Dolan on Analytical Training Solutions, designed to help practicing scientists strengthen method development, troubleshooting, and day-to-day decision-making in the lab.

View John Dolan’s chromatography courses >>

Add Separation Science as a preferred source on Google

Add Separation Science as a preferred Google source to see more of our trusted coverage

Meet the Author(s):

Speaker

  • John Dolan

    John Dolan

    John Dolan is considered to be one of the world’s top experts in HPLC. He has written more than 300 user-oriented articles on HPLC troubleshooting over the last 30 years, in addition to more than 100 peer-reviewed technical articles on HPLC and related techniques. His three books (co-authored with Lloyd Snyder), Troubleshooting HPLC Systems, Introduction to Modern Liquid Chromatography (3rd edn), and High-Performance Gradient Elution, are standard references on thousands of desks around the world. He has taught HPLC training classes around the world to more than 10,000 students.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...